26/09/2019- Bioimag ceases commercial activities- On November 23 Bioimag founders having 100% of the shares decided the ceasing of commercial activity of Bioimag due to lacks of founding. The votes were against a previous consideration to close de company to meet existing compromises. In the current situation is not possible to Bioimag as a company validating its technology Julian Daich explains in an announce.

11/09/2019- Bioimag Founders reacquire back shares from Extremadura Avante holding full control. In agreement with Extremadura Avante S.R.U which held 22,3% of Bioimag shares, Julian Daich and Marisela Vélez reacquired full control of Bioimag.

29/05/2018- Bioimag starts a new branding and corporate imaging development co founded by program D82 of the Extremadura Council involving FEDER founds for a total amount of 2500€. The economical support involved 1250€ and is oriented to the design and development of the production process that favors both the introduction of new or improved products in the market, and the development of processes that improve the efficiency, sustainability and productivity of activities. The objectives of this inversions are to establish product design actions, redesigns or adaptations of existing products, new and new packaging and packaging, which allow companies to reliably achieve a competitive advantage in the shortest possible time, solving functional, logistic or transport problems allowing access to New markets. This program is supported by the The Research and Innovation Strategy for the Intelligent Specialization of Extremadura (RIS3 Extremadura) is the instrument to articulate and implement the economic transformation necessary to make Extremadura a more competitive region, as well as the tool for the development of the European Operational Program 2014 -2020. The current operational program of the European Regional Development Fund of Extremadura, corresponding to the 2014-2020 programming period, contemplates the implementation ofAn aid program aimed at promoting and promoting the competitive improvement of Extremaduran SMEs. This action is part of the Thematic Objective OT 3: "Improving the competitiveness of SMEs", Investment Priority 3.3: "Support for the creation and expansion of advanced capabilities for the development of products and services", Specific Objective 3.3. 1: “Support for the creation and expansion of advanced capabilities for the development of products and services”. The percentage of cofinancing of the ERDF funds is 80%. More specifically Bioimag with this grant develops new materials and / or equipment necessary for the manufacture of the product, container or packaging. This support helps to consolidate the Bioimag's market possibilities.

03/02/2017 - Bioimag was granted by the Extremadura Council in the program D40/2016 to fund the research project" Development of matrix to transport stem cells with self-diagnostic ability and analytical methods for its characterization" involving FEDER funds from the European Union.


25/01/2016- We are interviewed by Extremadura Channel

06/04/2015- Biomag was selected by Agrotech StartUp Extremadura to form part of its business accelerator.

28/01/2015- Bioimag closed its first financial round receiving investment from the AVANTE found of Extremadura

07/11/2014- Patent WO2013190165 was granted in first European country (Spain)

04/09/2014- Bioimag participates in the VIVOIMAG RISE Marie Curie project to start in Q1 april 2015.  Belgian, Greek Israeli, and Spanish partners from industry and academy, will join efforts to develop bone implants and follow their integration in bone tissue using noninvasive magnetic resonance imaging.

16/08/2104- Bioimag was granted by ICEX with founds from the program Technological Fund  of Invest in Spain